No definition available.
Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced
PHLEBI_THROMBOP_LOWER_EXTREMITI_UNSPE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
314 |
4. Check minimum number of eventsNone |
314 |
5. Include endpointsNone |
314 |
6. Filter based on genotype QC (FinnGen only) |
306 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced
based on the number of shared cases.
Similar with more cases:
- Venous thromboembolism
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (not available in FinRegistry).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 306 | 169 | 137 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | 50.85 | 46.97 | 55.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 314
- Matched controls
- 3140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
+∞
307.7
314
61
B01AA03
ATC
warfarin; systemic
12.9
115.6
220
481
B01AB04
ATC
dalteparin; parenteral
13.4
68.0
71
67
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
9.6
36.6
46
55
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
11.2
33.3
37
37
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
8.7
29.6
40
52
B01AB05
ATC
enoxaparin; parenteral
3.3
24.1
157
730
M79.6
ICD-10 Finland
Pain in limb
2.8
18.1
169
920
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.6
17.1
67
222
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.6
16.6
63
204
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
13.2
16.2
28
23
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
12.2
14.6
26
23
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
20.4
14.4
21
11
4511A
ICD-9 Finland
Phlebitis and thrombophlebitis, Of deep vessels of lower extremities
20.4
14.4
21
11
K94
ICPC
Phlebitis/thrombophlebitis
10.3
12.5
24
25
D68.8
ICD-10 Finland
Other specified coagulation defects
17.3
11.8
18
11
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.7
11.1
37
109
N02AX02
ATC
tramadol; systemic, rectal
2.2
10.9
163
1027
I87.0
ICD-10 Finland
Postthrombotic syndrome
29.2
10.8
14
5
A46
ICD-10 Finland
Erysipelas
2.7
10.7
66
280
ZXE00
NOMESCO Finland
One hour or less
2.2
10.5
140
839
ZYC01, ,
SPAT
3.4
10.1
38
121
J01DA01
ATC
[U] cefalexin
2.3
10.1
217
1561
J45.1
ICD-10 Finland
Nonallergic asthma
3.4
9.4
36
116
D01AC02
ATC
miconazole; topical
3.2
9.3
38
128
K78
ICPC
Atrial fibrillation/flutter
3.0
9.0
42
153
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
9.0
8.9
18
21
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
7.7
8.6
19
26
R60.0
ICD-10 Finland
Localized oedema
2.6
8.1
51
217
D68.2
ICD-10 Finland
Hereditary deficiency of other clotting factors
34.3
8.1
10
*
K93
ICPC
Pulmonary embolism
11.2
7.9
14
13
ZXD05
NOMESCO Finland
Urgent procedure
2.0
7.4
107
644
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.5
6.9
48
215
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.5
6.8
24
73
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
8.1
6.7
14
18
A02BC01
ATC
omeprazole; systemic
2.0
6.7
100
606
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
6.7
91
534
R02
ICPC
Shortness of breath/dyspnoea
2.4
6.5
48
220
A02BA04
ATC
nizatidine; systemic
2.7
6.5
35
138
M10.9
ICD-10 Finland
Gout, unspecified
2.9
6.4
30
109
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
6.3
64
335
J01MA02
ATC
ciprofloxacin; systemic
1.8
6.3
133
896
J01FF01
ATC
clindamycin; systemic
1.9
6.3
94
567
R51
ICD-10 Finland
Headache
3.7
6.3
20
57
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
6.1
115
746
J01DB01
ATC
cefalexin; oral
2.1
6.1
252
2085
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
6.0
97
599
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
102
533
2.35
10.65
2.2
1.7
1.82
1.24
mg/l
0.80
74
431
188
1273
2.19
10.24
41.6
15.3
1.66
1.33
inr
3.19
65
366
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
76
3.64
7.85
5.5
1.9
0.32
0.33
u/ml
0.01
16
37
6
313
0.18
7.21
3.7
4.6
33.33
32.57
%
—
6
201
59
290
2.27
6.84
1.8
1.8
—
—
—
0
0
59
294
2.24
6.61
1.8
1.9
—
—
—
0
0
154
1106
1.77
5.78
5.8
4.4
34.18
35.05
g/l
1.01
142
1035
53
269
2.17
5.65
4.6
3.9
—
—
—
0
0
115
775
1.76
5.26
4.3
3.3
31.07
31.22
u/l
0.02
108
740
45
223
2.19
5.08
3.8
4.2
1.22
1.22
mmol/l
0.12
36
197
109
736
1.74
4.89
3.4
3.3
0.42
0.49
e6/l
0.22
85
552
70
420
1.86
4.64
2.0
1.9
—
—
—
0
0
54
298
1.98
4.59
8.0
6.5
2.27
1.36
mmol/l
0.81
47
228
8
8
10.22
4.54
1.8
3.1
1521.00
796.13
u/ml
—
8
8
130
948
1.63
4.24
3.5
3.3
—
—
—
0
0
78
500
1.75
4.12
5.4
3.9
205.73
157.01
ng/l
0.17
70
414
15
47
3.30
4.11
3.2
2.7
4.71
4.66
e9/l
0.02
15
47
11
327
0.31
3.89
7.2
8.0
—
—
—
0
0
184
1480
1.59
3.87
6.5
4.5
6.72
6.76
mmol/l
0.13
174
1393
15
49
3.16
3.86
3.3
3.2
62.40
58.86
%
0.47
15
49
44
240
1.97
3.86
2.2
2.4
24.19
32.59
u/l
1.43
36
199
12
31
3.98
3.53
1.0
1.0
—
—
—
0
0
92
640
1.62
3.52
2.3
2.1
3.16
3.17
mg/l
0.01
78
552
133
1020
1.53
3.29
3.1
2.6
110.17
141.40
ug/l
0.99
122
931
14
49
2.94
3.23
1.4
1.5
—
—
—
0
0
14
49
2.94
3.23
1.4
1.5
—
—
—
0
0
106
781
1.54
3.12
3.8
3.7
13.12
9.98
mg/mmol
0.20
75
492
67
443
1.65
3.11
2.5
2.8
1.26
1.17
e6/l
0.08
37
256
112
845
1.51
2.92
3.4
3.2
2073.53
1590.54
ng/l
0.37
94
717
222
1924
1.53
2.90
10.4
7.5
81.37
79.61
u/l
0.17
212
1791
46
280
1.75
2.88
3.2
2.7
13.12
7.80
umol/l
0.52
40
251
63
420
1.63
2.82
2.7
3.1
3.76
2.45
e6/l
0.33
34
234
42
251
1.78
2.80
5.1
3.4
6.10
5.72
kpa
1.39
42
241
152
1229
1.46
2.77
3.9
4.0
0.00
0.00
estimate
0.50
45
254
5
6
8.44
2.76
2.0
3.2
89.20
96.00
%
—
5
6
152
1233
1.45
2.70
5.0
5.4
0.00
0.00
estimate
-0.00
43
234
88
643
1.51
2.64
1.6
1.5
17.22
21.46
nmol/l
3.25
78
531
152
1240
1.44
2.58
4.0
4.0
0.00
0.00
estimate
-0.00
43
226
41
250
1.74
2.56
5.1
3.4
2.34
2.08
mmol/l
0.17
33
196
5
7
7.24
2.56
2.2
9.0
—
—
—
0
0
87
641
1.49
2.50
3.0
2.8
5426.47
5456.49
umol/l
0.00
79
546
167
1393
1.42
2.48
10.6
9.4
4.51
4.08
e9/l
1.33
151
1217
115
897
1.45
2.46
3.0
3.3
2.34
2.35
mmol/l
0.53
104
784
145
1181
1.42
2.45
8.6
5.4
1.22
1.21
mmol/l
0.16
134
1065
72
514
1.52
2.39
2.7
3.1
2.46
2.46
mmol/l
0.10
64
444
10
33
3.10
2.38
1.2
1.1
18.80
4.50
u/ml
—
5
16
159
1328
1.40
2.27
7.3
6.3
13.51
11.34
umol/l
0.58
153
1259
124
1001
1.39
2.13
2.6
2.2
73.89
78.26
nmol/l
1.16
116
883
31
187
1.73
2.03
1.5
1.6
—
—
—
0
0
13
57
2.34
2.00
7.2
2.7
15.73
15.28
%
—
7
30
137
1142
1.35
1.88
7.7
5.8
25.82
26.87
%
0.56
129
1069
126
1043
1.35
1.79
2.3
2.0
89.31
93.69
pmol/l
0.58
73
533
101
808
1.37
1.79
2.8
2.3
47.85
161.86
u/l
0.60
96
742
8
30
2.71
1.73
1.1
1.5
—
—
—
0
0
55
400
1.45
1.67
3.2
2.4
10.92
12.57
umol/l
1.15
50
374
5
14
3.61
1.62
1.0
1.1
—
—
—
0
0
49
351
1.47
1.61
3.5
2.4
16.69
21.84
%
2.20
39
308
25
154
1.68
1.55
1.4
1.8
—
—
—
0
0
201
1804
1.32
1.54
4.4
3.8
15.32
14.88
pmol/l
1.05
184
1604
32
212
1.57
1.50
3.8
2.8
4.04
4.25
kpa
0.38
32
202
9
40
2.29
1.41
1.4
1.1
25.17
30.44
u/l
—
9
32
131
1124
1.28
1.36
7.8
5.6
59.05
57.94
%
0.52
122
1051
0
39
0.00
1.34
0.0
2.9
—
19.56
—
0
9
11
54
2.07
1.34
1.1
1.2
—
—
—
0
0
6
24
2.53
1.31
1.0
1.0
—
—
—
0
0
5
18
2.81
1.29
1.0
1.2
—
—
—
0
0
6
25
2.43
1.25
1.2
1.5
—
—
—
0
0
19
117
1.66
1.21
3.1
3.2
501.64
2487.36
u/ml
0.71
11
102
146
1285
1.25
1.19
3.0
2.7
—
—
—
0
0
16
95
1.72
1.16
2.2
2.6
—
—
—
0
0
82
681
1.28
1.08
5.1
4.3
0.00
0.00
estimate
-0.00
41
229
254
2399
1.31
1.08
25.0
15.5
22.24
24.31
mg/l
0.61
217
1933
9
47
1.94
1.03
1.1
1.6
—
—
—
0
0
145
1293
1.23
1.01
8.9
6.1
1.22
1.21
mmol/l
0.50
113
1085
5
23
2.19
0.98
2.4
1.7
—
—
—
0
0
117
1025
1.23
0.96
5.5
4.1
39.60
45.11
ng/l
0.11
77
772
164
1489
1.21
0.93
4.1
3.0
65.76
49.33
u/l
0.96
148
1378
11
63
1.77
0.91
5.9
2.5
7.45
7.97
kpa
0.40
11
63
6
29
2.09
0.90
1.2
1.2
—
—
—
0
0
13
79
1.67
0.89
1.2
1.2
—
—
—
0
0
8
42
1.93
0.89
1.1
1.5
—
—
—
0
0
11
64
1.74
0.87
1.2
1.6
—
—
—
0
0
234
2210
1.23
0.85
5.5
4.6
2.02
2.51
mu/l
0.41
217
1984
12
73
1.67
0.83
1.9
1.5
—
—
—
0
0
126
1126
1.20
0.82
2.9
2.5
—
—
—
0
0
11
66
1.69
0.79
1.2
1.6
—
—
—
0
0
0
24
0.00
0.79
0.0
1.7
—
3.71
—
0
7
6
34
1.78
0.76
1.2
1.3
—
—
—
0
0
10
59
1.72
0.76
1.3
1.3
—
—
—
0
0
68
576
1.23
0.76
2.0
1.8
479.60
439.85
pmol/l
0.37
53
473
5
25
2.02
0.73
1.0
1.2
—
—
—
0
0
12
78
1.56
0.66
1.3
1.3
—
—
—
0
0
37
297
1.28
0.66
3.7
4.3
36.03
43.51
ug/l
0.07
31
248
88
779
1.18
0.63
2.3
2.0
208.00
178.33
u/l
0.15
81
728
9
139
0.64
0.62
6.8
2.9
31.82
33.57
u/ml
—
9
133
8
50
1.62
0.61
2.3
1.3
—
—
—
0
0
0
20
0.00
0.60
0.0
4.0
—
—
—
0
0
6
35
1.73
0.58
1.0
1.0
—
—
—
0
0
48
408
1.21
0.54
1.4
1.3
10.89
44.05
iu/ml
—
9
139
12
169
0.70
0.53
2.2
1.7
—
—
—
0
0
46
390
1.21
0.53
1.3
1.3
4.67
10.83
u/ml
0.84
15
161
236
2268
1.16
0.53
7.0
6.0
41.74
40.48
mmol/mol
1.18
223
2102
107
976
1.15
0.52
4.6
4.2
—
—
—
0
0
21
162
1.32
0.51
2.1
1.4
—
—
—
0
0
9
65
1.40
0.51
1.2
1.4
—
—
—
0
0
192
1828
1.13
0.46
5.8
4.2
15.78
13.34
mm/h
1.06
180
1663
38
322
1.20
0.45
1.6
1.4
—
—
—
0
0
13
96
1.37
0.42
1.2
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
38
326
1.19
0.40
1.4
1.4
—
—
—
0
0
5
35
1.44
0.39
3.2
3.9
—
—
—
0
0
61
678
0.88
0.38
4.3
4.5
21.50
21.72
%
0.04
28
343
73
663
1.13
0.38
1.8
1.7
1.45
1.32
mmol/l
0.94
60
548
64
582
1.13
0.33
2.7
2.3
—
—
—
0
0
78
844
0.90
0.32
5.5
5.3
2.31
2.96
ug/l
0.53
69
740
54
488
1.13
0.31
1.4
1.2
2.74
1.48
u/ml
0.27
20
130
44
489
0.88
0.29
2.7
3.2
0.77
0.77
ug/l
0.00
29
331
59
542
1.11
0.26
1.9
1.7
1193.35
1142.04
nmol/l
0.16
48
411
5
74
0.67
0.26
4.4
2.4
—
—
—
0
0
10
78
1.29
0.24
5.1
2.3
2.19
1.55
mg/l
—
10
71
10
78
1.29
0.24
6.7
2.5
26.65
25.34
mmol/l
—
10
78
23
200
1.16
0.23
3.3
3.1
66.59
63.56
ml/min/173m2
0.12
11
89
222
2269
0.93
0.22
4.1
4.1
1.39
1.25
mmol/l
2.56
207
2058
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
5
41
1.22
0.22
1.2
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
6
52
1.16
0.19
2.2
3.3
15.83
30.70
u/ml
—
6
52
17
148
1.16
0.17
4.4
3.5
4.02
2.16
mmol/l
0.63
11
116
223
2270
0.94
0.17
25.1
14.7
76.10
76.26
ml/min/173m2
0.03
199
1888
7
86
0.81
0.14
1.3
4.1
25.17
25.25
mmol/l
—
7
81
255
2523
1.06
0.11
28.5
17.9
139.85
139.67
mmol/l
0.64
250
2452
239
2364
1.05
0.10
5.1
4.7
6.33
6.01
mmol/l
3.05
221
2134
255
2526
1.05
0.10
29.2
18.0
3.97
3.99
mmol/l
0.66
250
2453
10
113
0.88
0.08
1.2
1.3
—
—
—
0
0
257
2553
1.04
0.06
14.9
10.7
26.90
24.51
u/l
1.53
249
2460
234
2356
0.97
0.05
4.4
4.5
1.41
1.49
mmol/l
2.07
219
2144
244
2426
1.03
0.04
5.6
5.1
2.62
2.69
mmol/l
0.54
228
2212
12
111
1.08
0.04
1.6
1.6
—
—
—
0
0
17
161
1.06
0.03
4.4
3.4
5.31
5.15
kpa
0.22
17
156
12
128
0.94
0.02
1.7
1.7
—
—
—
0
0
263
2639
0.98
0.02
34.4
22.6
4.41
4.43
e12/l
0.18
257
2560
263
2638
0.98
0.01
34.3
22.6
250.14
246.74
e9/l
0.32
258
2567
263
2638
0.98
0.01
34.8
22.6
39.55
39.73
%
0.16
246
2454
254
2548
0.98
0.01
29.5
18.3
82.13
79.41
umol/l
0.49
254
2548
11
108
1.02
0.00
1.2
1.8
—
—
—
0
0
237
2373
0.99
0.00
4.5
4.6
4.49
4.60
mmol/l
0.94
221
2178
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
81
0.99
-0.00
1.0
1.2
—
—
—
0
0
8
82
0.97
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
7.34
—
0
5
5
54
0.92
-0.00
1.2
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
67
0.89
-0.00
1.2
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (not available in FinRegistry).
Relationships between endpoints
↥Index endpoint: PHLEBI_THROMBOP_LOWER_EXTREMITI_UNSPE – Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced
GWS hits: 1
This endpoint is excluded (not available in FinRegistry).